Engineering Macrophages for Cancer Immunotherapy and Drug Delivery is a research paper published in Advanced Materials (2020). On theSindex it has a DataRank of 1.0. It has been cited 943 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
1.0
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Basic Research Program of China
Grant: 2017YFC1309100
National Basic Research Program of China
Grant: 2017YFA0205200
National Natural Science Foundation of China
Grant: 81671753
National Natural Science Foundation of China
Grant: 91959124
National Natural Science Foundation of China
Grant: 81227901
National Natural Science Foundation of China
Grant: 21804104
Fundamental Research Funds for the Central Universities
Grant: JB191211
Fundamental Research Funds for the Central Universities
Grant: JB191207
Fundamental Research Funds for the Central Universities
Grant: JB191208
Natural Science Basic Research Plan in Shaanxi Province of China
Grant: 2018JM2041
Natural Science Basic Research Plan in Shaanxi Province of China
Grant: 2019JQ-662
Key Research and Development Program of Shaanxi Province
Grant: 2019NY-085
Natural Science Basic Research Plan in Shaanxi Province of China
Grant: 2019JQ-139
National Institutes of Health
Intramural Research Program
NIBIB NIH HHS
NIH HHS
National 1000 Young Talents Program of China
National Institute of Biomedical Imaging and Bioengineering
Influential Citations
6
Fields of Study
MeSH Terms
Keywords
Additional file 1 of Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19
Additional file 1 of Nanovesicles derived from bispecific CAR-T cells targeting the spike protein of SARS-CoV-2 for treating COVID-19
Additional file 1 of Minimizing adverse effects of Cerenkov radiation induced photodynamic therapy with transformable photosensitizer-loaded nanovesicles
Additional file 1 of Minimizing adverse effects of Cerenkov radiation induced photodynamic therapy with transformable photosensitizer-loaded nanovesicles
Additional file 1 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 1 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 2 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 2 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 6 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 6 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 7 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 7 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 8 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 8 of LncRNA-PACERR induces pro-tumour macrophages via interacting with miR-671-3p and m6A-reader IGF2BP2 in pancreatic ductal adenocarcinoma
Additional file 1 of Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma
Additional file 1 of Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma
Additional file 2 of Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma
Additional file 2 of Interleukin 20 receptor subunit beta (IL20RB) predicts poor prognosis and regulates immune cell infiltration in clear cell renal cell carcinoma
Additional file 1 of Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer
Additional file 1 of Docetaxel-loaded M1 macrophage-derived exosomes for a safe and efficient chemoimmunotherapy of breast cancer